title: What is the future of noninvasive routes for protein- and peptide-based drugs?
authors.affiliation: Amneal Pharmaceuticals, 1 New England Ave, Piscataway, NJ 08854, USA.
authors.forename: Sameer
authors.initials: S
authors.lastname: Sachdeva
authors.affiliation: Amneal Pharmaceuticals, 1 New England Ave, Piscataway, NJ 08854, USA.
authors.forename: Shabbir
authors.initials: S
authors.lastname: Lobo
authors.affiliation: Amneal Pharmaceuticals, 1 New England Ave, Piscataway, NJ 08854, USA.
authors.forename: Tarun
authors.initials: T
authors.lastname: Goswami
mesh_terms: D001682:Biological Availability; D004333:Drug Administration Routes; D006801:Humans; D010455:Peptides / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D010455:Peptides
keywords: biotechnology; iontophoresis; microneedle; noninvasive; peptides; proteins